Effects of Conditioned Medium from Bone Marrow Cells on Human Umbilical Cord Perivascular Cells
Authors:
- 1 March 2021
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 27 (5-6) , 382-389
Abstract
Mesenchymal cells derived from human umbilical cord tissue are attracting increasing attention as a source for cell therapy. However, for applying the same in tissue engineering, it has been shown that the differentiation capacity of mesenchymal stromal cells is influenced by the tissue from which the cells are harvested. Thus, to explore the possibility of increasing the osteogenic capacity of mesenchymal stromal cells derived from the perivascular tissue of the human umbilical cord (HUCPVCs), we cultured these cells using conditioned medium (CM) derived from cultures of human bone marrow-derived mesenchymal stromal cells (hBMMSCs). However, hBM-CM contains a wide variety of growth factors, the amounts and ratios of which are considered to vary with the cell culture stage. Thus, we aimed to evaluate the effects of hBM-CM derived from different stages of hBMMSC culture on the osteogenic capacity of HUCPVCs. The stages of hBMMSC culture were defined as follows: Stage 1 (mitogenic stage) represented the period from the start of hBMMSC culture to 70% cell confluence; Stage 2 (confluent stage) represented the period from 70% confluence to the initiation of calcified nodule formation; and Stage 3 (calcification stage) represented the period following the initiation of calcified nodule formation. An analysis of growth factors contained in the CM obtained at each stage by enzyme-linked immunosorbent assay showed that IGF-1 was significantly elevated at Stage 2, whereas VEGF was significantly elevated at Stage 3. HUCPVCs were cultured using the CM from each of the stages for 1, 2, or 3 weeks. RUNX2 expression was the most upregulated at week 1 and then downregulated in all the groups. The expression of collagen 1 was significantly elevated in Stage 2 HUCs in week 3. ALP activity, ALP, and alizarin staining were higher in Stage 2 HUCs and Stage 3 HUCs. The calcium content was the highest in Stage 2 HUCs. The calcium content of HUCPVC obtained by the method used in this study was six times higher than that reported in the previous study. Collectively, our results show that the CM obtained at Stage 2 was most effective in driving the osteogenic differentiation of HUCPVCs.Keywords
This publication has 37 references indexed in Scilit:
- Characterization of conditioned medium of cultured bone marrow stromal cellsNeuroscience Letters, 2010
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative MedicineJournal of Dental Research, 2009
- Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic HierarchyPLOS ONE, 2009
- Role of hypoxia-inducible factor-1α in angiogenic–osteogenic couplingJournal of Molecular Medicine, 2009
- Human mesenchymal stem cells as a stable source of VEGF-producing cellsJournal of Tissue Engineering and Regenerative Medicine, 2008
- Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound HealingPLOS ONE, 2008
- Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell PopulationStem Cells, 2007
- Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2007
- Behavior of Transplanted Bone Marrow–Derived Mesenchymal Stem Cells in Periodontal DefectsJournal of Periodontology, 2006
- A New Human Somatic Stem Cell from Placental Cord Blood with Intrinsic Pluripotent Differentiation PotentialJournal of Experimental Medicine, 2004